INHSU 2026: Abstract Submissions

By Ana Balkandjieva

28 January 2026

People who use drugs
Drug policy
Harm reduction

Sunday 1 March

The 14th International Conference on Health and Hepatitis Care in Substance Users (INHSU 2026) will take place in Prague, Czech Republic from 6 to 9 October 2026.

INHSU 2026 abstract submissions are open until 1 March 2026.

INHSU 2026 invites abstract submissions showcasing original research that enhances the health and quality of life of people who use drugs. Abstracts on a broad range of topics, including health issues beyond hepatitis C, are welcome.

Full details about the submission process are available here.

Related materials

Joint Report on Drug Consumption Rooms in Europe

A report, released by EMCDDA and C-EHRN, presents the latest overview on drug consumption rooms in Europe. More

27 January 2024Advocate Advocacy Tools

Inspiring Short Film on Ireland’s Health Led Approach to Drugs Use

Watch Drugreporter’s video on Ireland’s innovative harm reduction tradition, and the country’s steps towards decriminalisation. More

27 January 2024Learn Care

Eliminating Hepatitis C in Europe: Report on Policy Implementation for People Who Inject Drugs

C-EHRN releases a report focusing on the availability of and access to interventions that constitute the HCV continuum of care specific for people who inject drugs in 35 European cities. More

6 February 2024Advocate Advocacy Tools

The Amsterdam Manifesto: A Catalyst for Change in Drug Policy

A diverse coalition of policymakers, scientists and civil society representatives unite in creating more humane drug policy by prioritizing the well-being of all impacted by the multifaceted challenges of illegal drug markets. Endorse NOW! More

10 February 2024Advocate Take Action!

Telemedicine at Syringe Access Programs May Address Barriers, Expand Access to HCV Treatment

A survey found telemedicine-based HCV treatment at a syringe access program could improve access to treatment among people who inject drugs. More

28 March 2024Learn Treatment

JAMA Paper: In People with Opioid Use Disorder, Telemedicine Treatment for HCV Was More Than Twice as Successful as Off-Site Referral

The study is one of only a few randomized controlled trials that have been conducted to determine the effectiveness of using telemedicine to improve health care access for vulnerable populations. More

11 April 2024Learn Treatment

UNAIDS Welcomes the Adoption of a Crucial Resolution Recognizing Harm Reduction Measures at the UN Commission on Narcotic Drugs

UNAIDS welcomes the adoption of a key resolution at the 67th session of the United Nations Commission on Narcotic Drugs, recognizing harm reduction for the first time as an important part of an effective public health response. More

11 April 2024Advocate Policy Statements